KM Gottesdiener

Statistics

Publications

Citations

290

H-Index

Active since

2007

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

KM Gottesdiener is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, clinical pharmacology evidence, and pharmacokinetics.

Publications per year

2007–2011

Publications

Safety, Tolerability, and Pharmacokinetics of Raltegravir After Single and Multiple Doses in Healthy Subjects

Marian Iwamoto, LA Wenning, AS Petry et al. · Clinical Pharmacology & Therapeutics · 2007 · 170 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects

Rajesh Krishna, AJ Bergman, Bo Jin et al. · Clinical Pharmacology & Therapeutics · 2008 · 100 citations

Life Sciences, Pharmacokinetics, Pharmacology +16

The effects of TPA023, a GABA <sub>A</sub> α <sub>2,3</sub> subtype-selective partial agonist, on essential tremor in comparison to alcohol

SL de Haas, RWM Zoethout, Kristien Van Dyck et al. · Journal of Psychopharmacology · 2011 · 20 citations

Medicine, Neurology, Pharmacology +16

1–3 of 3